These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34576305)

  • 1. Neuropeptide Y Reduces Social Fear in Male Mice: Involvement of Y1 and Y2 Receptors in the Dorsolateral Septum and Central Amygdala.
    Kornhuber J; Zoicas I
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valence-dependent effects of neuropeptide Y on the expression of conditioned fear and anxiety-like behavior: Involvement of the bed nucleus of the stria terminalis.
    Kornhuber J; Zoicas I
    Neuropharmacology; 2024 Mar; 246():109847. PubMed ID: 38218578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y reduces expression of social fear via simultaneous activation of Y1 and Y2 receptors.
    Kornhuber J; Zoicas I
    J Psychopharmacol; 2019 Dec; 33(12):1533-1539. PubMed ID: 31328614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y prolongs non-social memory in a brain region- and receptor-specific way in male mice.
    Kornhuber J; Zoicas I
    Neuropharmacology; 2020 Sep; 175():108199. PubMed ID: 32535011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain Region-Dependent Effects of Neuropeptide Y on Conditioned Social Fear and Anxiety-Like Behavior in Male Mice.
    Kornhuber J; Zoicas I
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y prolongs non-social memory and differentially affects acquisition, consolidation, and retrieval of non-social and social memory in male mice.
    Kornhuber J; Zoicas I
    Sci Rep; 2017 Jul; 7(1):6821. PubMed ID: 28754895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NPY Y2 receptors in the central amygdala reduce cued but not contextual fear.
    Verma D; Wood J; Lach G; Mietzsch M; Weger S; Heilbronn R; Herzog H; Bonaventure P; Sperk G; Tasan RO
    Neuropharmacology; 2015 Dec; 99():665-74. PubMed ID: 26314208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences.
    Deo GS; Dandekar MP; Upadhya MA; Kokare DM; Subhedar NK
    Brain Res; 2010 Mar; 1318():77-86. PubMed ID: 20059983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.
    Chu DQ; Cox HM; Costa SK; Herzog H; Brain SD
    Br J Pharmacol; 2003 Sep; 140(2):422-30. PubMed ID: 12970079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Neuropeptide Y in fear conditioning and extinction.
    Tasan RO; Verma D; Wood J; Lach G; Hörmer B; de Lima TC; Herzog H; Sperk G
    Neuropeptides; 2016 Feb; 55():111-26. PubMed ID: 26444585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of neuropeptide Y in the expression and extinction of fear-potentiated startle.
    Gutman AR; Yang Y; Ressler KJ; Davis M
    J Neurosci; 2008 Nov; 28(48):12682-90. PubMed ID: 19036961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: an NPY Y1 receptor independent effect.
    Fendt M; Bürki H; Imobersteg S; Lingenhöhl K; McAllister KH; Orain D; Uzunov DP; Chaperon F
    Psychopharmacology (Berl); 2009 Oct; 206(2):291-301. PubMed ID: 19609506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Existence of both neuropeptide Y, Y1 and Y2 receptors in pig spleen: evidence using subtype-selective antagonists in vivo.
    Malmström RE
    Life Sci; 2001 Sep; 69(17):1999-2005. PubMed ID: 11589515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pharmacological manipulations of neuropeptide Y and corticotropin-releasing factor neurotransmission on incubation of conditioned fear.
    Pickens CL; Adams-Deutsch T; Nair SG; Navarre BM; Heilig M; Shaham Y
    Neuroscience; 2009 Dec; 164(4):1398-406. PubMed ID: 19800945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue.
    Tovote P; Meyer M; Beck-Sickinger AG; von Hörsten S; Ove Ogren S; Spiess J; Stiedl O
    Regul Pept; 2004 Aug; 120(1-3):205-14. PubMed ID: 15177939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
    Silva AP; Carvalho AP; Carvalho CM; Malva JO
    Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional consequences of neuropeptide Y Y 2 receptor knockout and Y2 antagonism in mouse and human colonic tissues.
    Hyland NP; Sjöberg F; Tough IR; Herzog H; Cox HM
    Br J Pharmacol; 2003 Jun; 139(4):863-71. PubMed ID: 12813010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze.
    Bacchi F; Mathé AA; Jiménez P; Stasi L; Arban R; Gerrard P; Caberlotto L
    Peptides; 2006 Dec; 27(12):3202-7. PubMed ID: 16959374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and function of the amygdaloid NPY system: NPY Y2 receptors regulate excitatory and inhibitory synaptic transmission in the centromedial amygdala.
    Wood J; Verma D; Lach G; Bonaventure P; Herzog H; Sperk G; Tasan RO
    Brain Struct Funct; 2016 Sep; 221(7):3373-91. PubMed ID: 26365505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central neuropeptide Y modulates binge-like ethanol drinking in C57BL/6J mice via Y1 and Y2 receptors.
    Sparrow AM; Lowery-Gionta EG; Pleil KE; Li C; Sprow GM; Cox BR; Rinker JA; Jijon AM; Peňa J; Navarro M; Kash TL; Thiele TE
    Neuropsychopharmacology; 2012 May; 37(6):1409-21. PubMed ID: 22218088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.